Fellow
Dr. Fanny IP
Chief Scientific Officer, Hong Kong Center For Neurodegenerative Diseases,
State Key Laboratory of Molecular Neuroscience, HKUST
Dr. Fanny Ip is the Chief Scientific Officer of the Hong Kong Center for Neurodegenerative Diseases and is affiliated with the State Key Laboratory of Molecular Neuroscience at HKUST. With over 30 years of research experience, she is well-versed in neuroscience, drug discovery, clinical diagnostics, and therapeutics. Her early research focused on neurotrophic factors and the potential benefits of traditional Chinese medicine for neurodegenerative and neurological disorders. She established neuro-drug discovery platforms to screen for small molecules and medicinal herbal extracts. Dr. Ip also leads clinical research studies on blood biomarkers for early detection and diagnosis of Alzheimer's disease. She has published 70 scientific papers, co-invented 35 patents, and licensed out patented technologies for preclinical development that resulted in a Phase 1 clinical trial.
Furthermore, Dr. Ip has successfully translated the research findings into products and services that serve the community. As the Director of two startup companies spun out from HKUST, both have received investment funding for further development. Cognitact® is translating cutting-edge research efforts into a risk prediction, diagnostic, and disease monitoring tool for dementia, aiming to detect Alzheimer's disease before its symptomatic stage using blood. Infitech® is to transform over two-decade research findings on traditional Chinese medicine into herbal-based nutritional and medicinal products for brain health targeting to enhance neuronal communication and synaptic plasticity of the brain.
Company Websites
Hong Kong Center for Neurodegenerative Diseases (HKCeND): https://www.hkcend.org/zh/
Cognitact: https://www.cognitact.com/
Infitech Limited: https://www.cogniherbs.com/